Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis
Platelet-Rich Plasma vs Autologous Blood Injection to Treat Plantar Fasciitis: A Prospective Randomized, Double-Blinded, Controlled TrialFoot Ankle Int . 2022 Sep;43(9):1211-1218.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Sixty patients with plantar fasciitis were randomized to receive an ultrasound-guided injection of platelet-rich plasma (n=30) or autologous blood product. The outcomes of interest included pain on a Visual Analog Scale (VAS) and the Foot and Ankle Disability Index (FADI), measured at 1, 3 and 6 months. Results revealed no significant differences between the two groups in all outcomes, at all time...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue